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Difference spectroscopic investigations on the  inter- 
action of brain hexokinase with glucose and glucose 6- 
phosphate (Glc-6-P) show that  the  binary complexes 
E-glucose and  E-Glc-6-P give very  similar UV differ- 
ence spectra. However, the  spectrum of the  ternary E- 
glucose-Glc-6-P complex differs markedly from the 
spectra of the  binary complexes, but resembles that 
produced by the E-glucose-Pi complex. 
Direct  binding  studies of the  interaction of Glc-6-P 
with  brain hexokinase detect only a single  high-affin- 
ity binding site for Glc-6-P (KO = 2.8 PM). In the 
ternary E-glucose-Glc-6-P complex, Glc-6-P has a 
much higher  affinity  for  the enzyme (KO = 0.9 p ~ )  and
a single binding site. Ribose 5-phosphate displaces Glc- 
6-P from E-glucose-Glc-6-P only, but not from E-Glc- 
6-P complex. It also fails  to displace glucose from E- 
glucose and E-glucose-Glc-6-P complexes. Scatchard 
plots of the binding of glucose to brain hexokinase 
reveal only a single binding site but show distinct 
evidence of positive cooperativity, which is abolished 
by Glc-6-P and Pi. These ligands, as well as ribose 5- 
phosphate, substantially  increase  the  binding  affinity 
of  glucose for  the enzyme. 
The  spectral evidence, as well as the  interactive na- 
ture of the sites binding glucose and  phosphate-bearing 
ligands, lead us to conclude that  an allosteric  site  for 
Glc-6-P of physiological relevance occurs on the  en- 
zyme only in the presence of glucose, as a common 
locus where Glc-6-P, Pi, and ribose 6-phosphate bind. 
In  the absence of glucose, Glc-6-P binds  to  the nzyme 
at  its active  site  with high affinity. We also discuss the 
possibility that, in the absence of glucose, Glc-6-P may 
still bind to  the  allosteric  site,  but  with  very low affin- 
ity, as has been observed in studies on the reverse 
hexokinase reaction. 
Brain hexokinase, the  first enzyme of the glycolytic path- 
way, activates glucose for the degradation process by catalyz- 
ing its phosphorylation using ATP as  the phosphoryl donor. 
It is a crucial enzyme in  the regulation of energy metabolism 
in  the brain,  and owes its  control  properties to inhibition by 
its reaction product, Glc-6-P’ and de-inhibition by substrate 
ATP and effector Pi. The enzyme is a monomer of 98 kDa. 
(1-3). 
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In spite of extensive work carried out on this enzyme, an 
unanswered question to date is whether the regulatory action 
of these ligands occurs at  the acitve site or at allosteric site(s) 
(4-7). One suggestion has Glc-6-P inhibiting enzyme activity 
by binding to a “high-affinity” allosteric site (KO = 2.5 p ~ )  
in addition to  the “low-affinity” product site, implying that 
two  molecules of Glc-6-P can interact with the enzyme (6). 
In another viewpoint, Glc-6-P inhibits enzyme activity by 
binding tightly to  the product site (7). 
In our laboratory, an observation made during the chro- 
matography of the enzyme on phosphocellulose suggested a 
role for glucose in the interaction of these phosphate-bearing 
ligands with brain hexokinase. Briefly, the enzyme in Tris- 
HC1 buffer (pH 7.7) containing 10 mM glucose  could  be bound 
to the phosphocellulose matrix and  then eluted by the phos- 
phate-bearing ligands at concentrations comparable to their 
K, values. The presence of glucose in the buffer during 
chromatography was crucial. In  its absence the enzyme  could 
not be eluted from the column (8, 9). 
These results suggested a possible role for glucose in the 
interaction of the phosphate-bearing ligands with brain hex- 
okinase, a view also implied earlier (10). With a view to 
clarifying the role of glucose in this interaction, we have 
carried out equilibrium binding and difference spectroscopic 
studies with the enzyme. The evidence suggests that  an allo- 
steric site for Glc-6-P of physiological significance does not 
preexist on the enzyme, but requires its prior interaction with 
glucose. Furthermore, in the absence of glucose, Glc-6-P binds 
to  the product site. 
MATERIALS AND METHODS 
ChemiCals-D-[U-’4C]~lUCOSe (specific activity, 255 and 292 mCi/ 
mmol) and 32Pi as phosphoric acid (carrier-free) were obtained from 
the Isotope Division, Bhabha Atomic Research Centre, Trombay, 
Bombay, India. D-[U-’4C]Glucose 6-phosphate (specific activity, 282 
mCi/mmol), was obtained from Amersham, United Kingdom. 
N-Ethyl morpholine, ribose 5-phosphate, and 2-mercaptoethanol 
were obtained from Sigma. Ammonium sulfate (enzyme grade) was 
from Schwarz-Mann. Glucose 6-phosphate dehydrogenase, NADP, 
ATP, and Glc-6-P were obtained from Boehringer Mannheim, Fed- 
eral Republic of Germany. All other chemicals were Analytical or 
Guaranteed Reagent quality obtained from British Drug Houses or 
Merck. 
Preparation of Enzyme-Type I hexokinase was purified from 
bovine brain mitochondria by the method detailed before (11). The 
purified enzyme was stored at 4 “C in 10 mM phosphate buffer (pH 
7.7) containing 10 mM glucose, 1 mM EDTA, and 5 mM 2-mercapto- 
ethanol. Assay of enzyme activity and determination of protein con- 
centration have also been described previously (11). The specific 
activity of the enzyme used in these experiments was usually between 
50 and 80 units/mg of protein. 
Removal of Glucose from the Enzyme-Because earlier methods 
using exhaustive dialysis for removal of glucose failed to free the 
enzyme completely from this ligand, an alternative procedure was 
followed. In  this experiment, the enzyme was precipitated three times 
to 70% saturation with ammonium sulfate in 100 mM phosphate 
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buffer (pH 8.0). This was  followed  by exhaustive dialysis (four 
changes of  500 ml of buffer over 24 h).  The removal of glucose by this 
method was confirmed by the glucose 6-phosphate dehydrogenase- 
linked assay. Glucose contamination detected by this method was 
-0.5 pM. 
Ligand Binding Experiments-Binding of ligands to  the enzyme 
was studied using the method of Colowick and Womack (12, 131, 
employing a home-built Lucite dialysis cell. The dimensions of the 
cell  were closer to  the smaller one suggested by  Brown and Reichard 
(14) and had a lower chamber volume of  0.4  ml and  an upper chamber 
volume of 1.0 ml. The dialysis membrane was a square, cut from 
ordinary Spectrapor dialysis tubing. The flow rate from the cell  was 
maintained at  3.5 ml/min and 0.7-ml fractions were collected. 0.6-ml 
aliquots in Brays solution were counted in an LKB 1219 Rackbeta 
counter. 
All binding experiments were carried out in 100 mM NEM acetate 
buffer (pH 8.0) containing  5 mM 2-mercaptoethanol and other  addi- 
tions as detailed in figure legends. Diffusion of the charged ligands, 
~-[U- '~c]Glc-6-P and ?'Pi showed a tendency to be retarded by the 
dialysis membrane. This problem was overcome by the addition of 
0.1 and 0.2 M KCl, respectively, to  the buffer during the course of the 
binding experiment. In final  control runs carried out with each labeled 
ligand, addition of excess unlabeled ligand had no effect on the steady- 
state concentration of isotope in the effluent. Loss of isotope from 
the upper chamber during dialysis was <3%. All binding experiments 
were carried out at 25 k 2 "C. 
Results were plotted according to Scatchard (15) where 
,i = concentration of bound ligand/total enzyme concentration and 
[ F ]  is the concentration of free ligand. The intercept ( n )  on  the x- 
axis is the number of binding sites, and  the slope is the reciprocal of 
the dissociation constant for the complex. 
Ultraviokt Difference Spectra-These were recorded on a Cary- 
17D spectrophotometer. Matched 1.0-cm path-length  quartz cuvettes 
were  used. The base line was recorded with both cuvettes  containing 
the same enzyme solution in 10 mM NEM acetate buffer (pH 8.0) 
and 5 mM 2-mercaptoethanol. In these  experiments sugar ligands at 
the concentrations used did not show any absorbance in  the range of 
wavelength scanned. The difference spectrum produced by interaction 
of the ligand was recorded after  the  addition of saturating  concentra- 
tions of the ligand to the sample cuvette and an equal volume of 
buffer to the reference cuvette. At the end of each spectral scan, 
addition of the same  concentration of ligand to  the reference cuvette 
restored the original base line. This precaution was taken  to make 
sure that  there was no time-dependent baseline shift. Recorded spec- 
tra were corrected for base-line deviations. All spectra were recorded 
at 22 +. 1 "C. 
RESULTS 
Ultraviolet  Difference Spectra Induced by Sugar Ligands- 
Fig. 1A presents the UV difference spectra resulting from the 
addition of saturating levels of Pi or glucose to  the enzyme. 
Although Pi by itself does not cause any  spectral  perturbations 
in the 260-300 nm region, the glucose spectrum is character- 
ized by the presence of several positive and negative peaks in 
this  spectral range.2 Addition of saturating levels of Glc-6-P 
induces a difference spectrum (Fig. 1B) very similar to  that 
of glucose (Fig. 1A). Binding of Pi to  the enzyme does not 
produce any difference spectrum (Fig. l A ) ,  but  its interaction 
with the enzyme in the presence of glucose (Fig. IC) gives 
rise to a  spectrum which cannot be accounted for simply as 
the additive effect of these two ligands. This indicates the 
formation of an E-glucose-Pi complex where the two ligand 
sites  are mutually interactive. Fig. 1D is the difference spec- 
trum produced by the  interaction of Glc-6-P with the enzyme 
in the presence of glucose. This spectrum is clearly different 
from that produced by the binding of glucose (Fig. 1A) or 
Glc-6-P (Fig. 1 B )  with the enzyme and indicates that both 
? Earlier  experiments using enzyme from which glucose had been 
removed by conventional dialysis failed to give glucose-induced dif- 
ference spectra. However, when the  present method for removal of 
glucose  by multiple precipitations was used, difference spectra were 
obtained, indicating  contamination of glucose in earlier samples of 
the enzyme. 
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FIG. 1. Ultraviolet difference spectra of brain hexokinase 
induced by different ligands. In A,  reference cuvette, 11 p~ 
hexokinase; sample cuvette, 11 p~ hexokinase + 200 p~ glucose are 
shown (---). Reference cuvette, 13 p M  hexokinase; sample cuvette, 
13 &M hexokinase + 1 mM Pi are indicated (-). B is reference 
cuvette, 11 pM hexokinase; sample cuvette 11 p M  hexokinase + 100 
pM Glc-6-P. C is reference cuvette, 13.5 p M  hexokinase + 10 mM 
glucose; sample cuvette, 13.5 p M  hexokinase + 10 mM glucose + 1 
mM P,. D shows reference cuvette, 17 pM hexokinase + 10 mM glucose; 
sample cuvette, 17 pM hexokinase + 10 mM glucose + 100 p M  Glc-6- 
P. 
glucose and Glc-6-P can  bind simultaneously to  the enzyme, 
a result reported earlier (6, 7, 9, 10, 17). It is interesting to 
note that, in the presence of glucose, Glc-6-P  and Pi induce 
similar difference spectra (Fig. I, C and D). 
Binding of Glc-6-P to Brain Hexokinase in the Presence and 
Absence of Glucose-The number of binding sites (n) and 
dissociation constants (KD) of Glc-6-P with respect to  the 
enzyme  were determined as described under "Materials and 
Methods." 
In two different experiments where enzyme concentrations 
were 4.0 and 8.8 FM, and  Glc-6-P  concentrations were varied 
from 4 to 104 pM, free and bound ligand concentrations were 
determined. Scatchard  plot analysis of these  data gave n = 
0.82 2 0.14 and KD = 2.8 f 0.48 pM (Fig. 2A). These results 
clearly indicate that  there is a single high-affinity site for Glc- 
6-P on the enzyme. 
Binding of Glc-6-P with hexokinase was also studied in the 
presence of glucose (2.5 mM). The resultant  Scatchard  plot 
(Fig. 2B) analysis gave n = 0.89 k 0.05 and KIl = 0.9 & 0.05 
FM. 
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FIG. 2. Scatchard plots of the binding of glucose 6-phos- 
phate to brain hexokinase in the presence and absence of 
glucose. The samples were in 100 mM NEM acetate buffer (pH 8.0) 
containing 0.1 M KC1 and 5 mM 2-mercaptoethanol. Binding was 
studied at 25 f 2 "C. In A, the results  presented  are from two different 
experiments where enzyme concentrations were 4 and 8.8 p~ and 
Glc-6-P  concentration was varied from 4 to 104 phi. Least-squares fit 
gave n = 0.82 & 0.14 and KO = 2.8 f 0.48 pM. For B, the sample 
contained 8.0 p M  enzyme and 2.5 mM glucose. Concentration of Glc- 
6-P was varied from 7 to 200 pM. Least-squares fit analysis gave n = 
0.89 f 0.05 and KO = 0.9 & 0.05 pM. 
This dissociation constant for Glc-6-P determined in the 
presence of glucose is 3-fold smaller than  in  the absence of 
glucose. This observation again supports the formation of an 
E-glucose-Glc-6-P complex and suggests synergistic interac- 
tion between the two sugar binding sites on the enzyme. 
Similar observations have been made by earlier workers (6,9, 
10, 17). 
Binding of Glucose-Binding of glucose  was monitored us- 
ing [U-'4C]glucose. Fig. 3A shows the result of a typical 
binding experiment. In several different experiments where 
enzyme concentrations were varied from 25 to 125 WM and 
glucose from 4 to 1000 WM, a downward curvature to the 
Scatchard  plot was always obtained. By extrapolation of the 
data in the higher concentration range of glucose, we have 
determined an average n = 0.67 f 0.18 binding sites  and KO 
= 67 f 4 MM. The observed curvature of the Scatchard plot is 
a  characteristic  feature of positive cooperativity (18, 19). For 
bovine brain hexokinase, which is a monomeric enzyme, this 
is a rather surprising result. The Scatchard plots for the 
binding of glucose in the presence of 100 p M  Glc-6-P (plot 
not  presented)  and  5 mM Pi (Fig. 3B)  are  straight lines giving 
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FIG. 3. Scatchard  plots  for  the  binding of glucose  to  brain 
hexokinase  in the  absence and presence of Pi. The samples were 
in 100 mM NEM acetate buffer (pH 8.0) containing 5 mM 2-mercap- 
toethanol.  In A ,  enzyme concentration was  120 p~ and amounts of 
glucose varied from 4 to 1000 p ~ .  n = 0.86 * 0.23 binding sites and 
K D  = 72 f 4 p ~ .  The sample in B contained 5 mM Pi. The results are 
presented from two different experiments where enzyme concentra- 
tions were  87.2 and 27.5 p ~ ,  respectively, and glucose concentration 
was varied from 8 to 600 pM. Least-squares fit analysis gives n = 0.51 
& 0.07 binding sites with a KO = 24 ? 4 pM. 
TABLE I 
Dissociation constants and stoichiometzy of binding of  different 
ligands with  brain hexokinase 
Values shown are mean f S.D. 
Serial no. Ligand Complex Binding sites KO 
n P M  
1. Glc-6-P E-Glc-6-P 0.82 f 0.14 2.8" f 0.48 
2. Glc-6-P E-glucose-Glc-6-P 0.89 & 0.05 0.9" & 0.05 
3. Glucose E-glucose 0.67 -C 0.18 67.0 & 4 
4. Glucose E-glucose-Pi 0.51 f 0.07 24.0 2 4 
5. Glucose E-glucose-Glc-6-P 0.50 f 0.03 7.0 & 0.46 
6. Pi E-Pi 0.63 f 0.17 197.0' f 55 
7. Pi E-glucose-Pi 0.51 jI 0.11 56.0b & 12 
8. Rib-5-P E-glucose-Rib-5-P ND' -2500 
a Binding studies were carried out in the presence of 0.1 M KC1 in - 
the buffer. 
* Bindine studies were carried out  in the presence of 0.2 M KC1 in 
I 
the buffer. 
ND, not determined. 
K,  values of 7 & 0.46 and 24 IC_ 4 GM, respectively, and  about 
0.5 binding sites for glucose in the presence of these ligands. 
Interaction of Pi with the Enzyme-Inorganic phosphate, 
which is a regulatory ligand of brain hexokinase, is known to 
de-inhibit the Glc-6-P inhibited enzyme  (21-24). Direct bind- 
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FIG. 4. Effect of the addition of increasing amounts of  Rib- 
5-P to E-['4C]Glc-6-P in the absence and presence of glucose. 
The samples were in 100 mM NEM acetate buffer (pH = 8.0) con- 
taining 0.1 M KC1 and 5 mM 2-mercaptoethanol. a, 5.4 p M  enzyme 
and 4.2 pM ["C]Glc-6-P; b, 5.2 p~ enzyme, 2.5 mM glucose and 4.2 
p M  ['4C]Gl~-6-P. 
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FIG. 5. Effect of the addition of Rib-5-P or Glc-6-P on the 
binding of glucose with brain hexokinase. The samples were in 
100 mM NEM acetate buffer (pH 8.0) containing  5 mM 2-mercapto- 
ethanol and a, 53 p~ hexokinase and 8 PM ['4C]glucose; b, 16.4 pM 
hexokinase, 100 p~ Glc-6-P and 8 pM ['4C]glucose; and c, 47 p M  
enzyme and 6 p M  ['4C]glucose. 
ing of phosphate  with  the  enzyme  in  the  presence  and  absence 
of glucose was studied using 32Pi (Table I). The enzyme 
concentrations  used  in  these  experiments were 43 and 70 pM, 
respectively. The Pi concentrations were varied  from 10 p M  
to 5 mM. 
Because charged  ligands showed a tendency  to  exhibit  non- 
specific adsorption  on  the  surface of the dialysis membrane, 
0.2 M KC1 was included  in  the buffer.  Dissociation constants 
determined  in  the  presence  and  the  absence of glucose were 
56 k 12  and 197 f 53 p ~ ,  respectively, with a  single binding 
site for this ligand, a result qualitatively similar to that 
reported  earlier (17). 
Displacement of r4C]Glc-6-P  from-E-r4ClGlc-6-P and E-  
gluco~e-~~C]Glc-6-P by Ribose 5-Phosphate-In an  attempt 
to  differentiate between the  Glc-6-P  binding  sites  in  E-Glc- 
6-P  and  E-glucose-Glc-6-P complexes, we employed Rib-5-P 
to  displace Glc-6-P  from  these complexes. We observed that 
the pentose phosphate displaces [14C]Glc-6-P only in the 
presence of glucose ( i e .  from  E-gl~cose-['~C]Glc-6-P)  and  not 
in  its  absence ( i e .  from E-[14C]Glc-6-P)  (see Fig. 4). Because 
glucose and  Glc-6-P  exhibit synergistic  binding, an  apparent 
displacement of Glc-6-P from E-glucose-Glc-6-P may also 
arise if glucose is displaced by Rib-5-P  and synergism  between 
the two sites is lost. This possibility was eliminated in an 
experiment in which the displacement of ['4C]glucose was 
measured  in E-['4C]glucose and E-['4C]glucose-Glc-6-P com- 
plexes. The  result showed that  the  addition of Rib-5-P 
brought about an increase in glucose binding (Fig. 5). The 
dissociation constant of Rib-5-P in E-glucose-Rib-5-P was 
estimated  to be -2.5 mM (Table  I). 
I t  is interesting to note that all the phosphate-bearing 
ligands (i.e. Pi, Glc-6-P, Rib-5-P) have a similar effect on  the 
binding of glucose to  the enzyme (Table  I). 
Rib-5-P was reported  to have no  inhibitory effect on hexo- 
kinase (4). Because we observed  competitive displacement of 
Glc-6-P, we re-investigated  the  inhibitory  properties of Rib- 
5-P  in  kinetic  experiments  (not shown). In  these  experiments, 
Rib-5-P was found to inhibit the enzyme, albeit weakly. 
Assuming inhibition by Rib-5-P  to  be competitive with re- 
spect  to  ATP,  an  apparent K ,  (-3 mM) was obtained. This  is 
in  agreement with the KO of Rib-5-P  in  the E-glucose-Rib-5- 
P complex (see Table  I). 
DISCUSSION 
The  strong  similarity  in  the difference spectra produced by 
the  interaction of glucose or Glc-6-P with the enzyme allows 
us  to conclude that  Glc-6-P by itself binds  to  the  catalytic 
site of the enzyme. That this is a single high-affinity site 
(KD = 2.8 & 0.48 p ~ )  is  evident from our  binding  data. Lazo 
et al. (6), contradicting earlier results of Chou and Wilson 
(25) and Ellison et al. (17), proposed that  there  are two binding 
sites for Glc-6-P on the enzyme, a high-affinity regulatory 
site (KD = 2.5 pM)  and a  low-affinity catalytic one.  Solheim 
and  Fromm (7) have pointed  out several flaws in  the  data of 
Lazo et al. (6) which cast some doubts  on  their conclusion. 
More  serious, Ureta et al. (26), using an enzyme preparation 
similar  to  that  used by Lazo et al. (6), have  concluded, on  the 
basis of their kinetic data, that there cannot be a major 
difference in  the relative affinities of Glc-6-P for  regulatory 
and  catalytic  sites.  These  authors have obtained a Ki value of 
200 p~ for the  inhibitory  site  on  brain hexokinase, as com- 
pared with  a  value of 2.5 p~ determined by Lazo et al. (6). 
This difference of 2 orders of magnitude  is difficult to explain. 
Again, if there  are two sites for Glc-6-P of similar  affinity, 
then neither Chou and Wilson (25) nor Ellison et al. (17) 
should have failed to detect them in their binding experi- 
ments.  Our  results  are  in  agreement with the view of Solheim 
and  Fromm (7) that,  in  the  concentration range  in which it 
functions as a regulator, Glc-6-P  binds  to  the active site of 
the enzyme with high  affinity. However, this does not mean 
that  Glc-6-P necessarily performs  its regulatory function at  
the  active  site, for these  binding  experiments were carried  out 
in  the  absence of glucose, which would make a  difference as 
shown below. Our conclusion that  Glc-6-P  binds  to  the  active 
site of brain hexokinase receives strong support from the 
results of our  experiments  on  the  mapping of sugar ligand 
binding  sites  on  the enzyme  using  magnetic  resonance meth- 
ods. In  these  experiments,  the  distances  determined from the 
reference Mn(I1) at  the  tight-binding  site of the enzyme  (27) 
to  the  different  protons of glucose in  the E-Mn(I1)-glucose 
complex (28) are close to  the values obtained  for  the  corre- 
sponding  protons of Glc-6-P  in  the  E-Mn(II)-Glc-6-P com- 
plex.3 
The  data of Solheim  and  Fromm (7) and of Sols  and  his 
G.K. Jarori, S.R. Kasturi, and U.W. Kenkare, manuscript in 
preparation (1988). 
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co-workers (5, 26) provide evidence for the existence of a 
relatively low-affinity second Glc-6-P binding site on brain 
hexokinase. These data are suggestive of a low-affinity Glc- 
6-P inhibition rather  than high-affinity Glc-6-P inhibition at 
high Glc-6-P concentrations.  Earlier,  Jarori (29) and  Kenkare 
et al. (9) presented spectroscopic data  to show that,  at high 
concentrations of Glc-6-P (-2.5 mM) the UV difference spec- 
trum is changed, implying that more than one molecule of 
Glc-6-P interacts with the enzyme. However, such a weak 
binding second site  cannot have any regulatory function in 
the context of known facts about hexokinase regulation in 
vitro. 
The binding and difference spectroscopic data presented in 
this paper provide strong confirmation of earlier observations 
regarding the effect of glucose on the binding of Glc-6-P to 
the enzyme, and  the formation of E-glucose-Glc-6-P complex 
(6, 7, 9, 10, 17). In the presence of glucose, the dissociation 
constant of Glc-6-P for the enzyme shows a 3-fold decrease, 
and, more importantly, only one binding site is observed. 
Earlier, Ellison et al. (17) had also observed only one binding 
site for Glc-6-P on the enzyme and  a reduction of its KIj from 
0.50 to 0.12 pM in the presence of glucose. 
It is instructive to compare the difference spectral data for 
brain and yeast hexokinase in the presence of glucose and 
Glc-6-P, in terms of the regulatory properties of these en- 
zymes. Roustan et al. (30) have shown that glucose and Glc- 
6-P induce the same spectral effects in yeast hexokinase, 
concluding that they both bind to the active site of the 
enzyme. In  brain hexokinase, too, we have observed similar 
effects and drawn the same conclusion. Similarity between 
the two  enzymes,  however, ends here. For Roustan et al. (30) 
also found that glucose and Glc-6-P together do not produce 
any additive spectral effects, as expected from competitive 
binding. It is  to be noted that yeast hexokinase is not inhibited 
or regulated by Glc-6-P. On the other hand, brain hexokinase, 
which is so regulated, behaves differently in an identical 
experiment. In the presence of both ligands it gives a differ- 
ence spectrum quite unlike that induced by each ligand sep- 
arately (Fig. 1D). Because the regulatory behavior of Glc-6-P 
in the forward hexokinase reaction is observed only in the 
presence of glucose, it follows that, in the ternary E-glucose- 
Glc-6-P complex represented by this difference spectrum (Fig. 
I D ) ,  Glc-6-P is bound in the regulatory or allosteric mode. 
The very high affinity ( K D  = 0.9 f 0.05 p ~ )  with which  Glc- 
6-P binds to  the enzyme in this complex is consistent with 
this hypothesis. Yeast hexokinase is not subject to regulation 
by Glc-6-P and does not need a  site different from its product 
site for binding Glc-6-P,  and hence does not show a change 
in its difference spectrum when Glc-6-P binds to it in the 
presence of glucose. 
The displacement of Glc-6-P by Rib-5-P from the ternary 
E-glucose-Glc-6-P complex but  not from the binary E-Glc-6- 
P complex (Fig. 4) clearly reflects the distinct locations of 
Glc-6-P in  its regulatory and product configurations. It calls 
to mind the proposal made by Fromm and his co-workers (7, 
32) that Glc-6-P,  after  its formation as  a product from glucose, 
may still  bind within the active site domain, but  not at  the 
glucose subsite. This difference in the locations of the two 
binding sites is reflected in the different specificities for the 
binding of the glycosyl portions of glucose and Glc-6-P as 
observed by Crane and Sols (4). As expected from its compe- 
tition with Glc-6-P when bound in  the regulatory mode in E- 
glucose-Glc-6-P complex, Rib-5-P caused significant inhibi- 
tion of the enzyme by apparently displacing ATP from the 
active site (Ki - 3 mM). This inhibition by Rib-5-P runs 
counter to the data of Crane and Sols (4), who failed to 
observe any inhibition by Rib-5-P. 
The close similarity of the difference spectrum produced by 
the E-glucose-Glc-6-P complex with that of E-glucose-Pi is 
strongly suggestive of a common locus for Pi and  the phos- 
phate moiety of Glc-6-P in its allosteric configuration. The 
stimulation of glucose binding caused by all the phosphate- 
bearing ligands such as Glc-6-P, Rib-5-P (Fig. 5), and Pi 
(Table I) and increase in the affinity of Glc-6-P (Fig. 2B)  and 
Pi (Table I) in the presence of glucose shows that, in the 
ternary complexes of these ligands, the phosphate binding 
subsite is the one that interacts with the glucose binding site. 
The apparent positive cooperativity exhibited by  glucose bind- 
ing to  the enzyme (whatever the reason) is also abolished by 
the phosphate ligands Glc-6-P  and Pi, implying binding at a 
common  locus. 
Considering all the data available, we conclude as follows: 
( a )  In the range of concentrations in which Glc-6-P functions 
as  a  substrate or regulator, it can bind strongly either to  the 
catalytic site or to the allosteric site4 (in the presence of 
glucose) but  not to both with equal affinity at  the same time. 
( b )  In  the forward reaction in the presence of glucose, it binds 
at  the allosteric site. In the reverse reaction it binds mainly 
at  the catalytic site. ( c )  Increased binding of Glc-6-P observed 
in the presence of glucose is due to  its binding with higher 
affinity at  the allosteric site. ( d )  The high-affinity allosteric 
site for Glc-6-P observed in the presence of glucose  becomes 
a weak binding site for this ligand in the absence of glucose. 
We can now explain the high-affinity binding of Glc-6-P to 
brain hexokinase in the reverse reaction as shown by Solheim 
and Fromm (7). The weak binding of Glc-6-P to  the second 
site observed by Solheim and Fromm (7) as well as  Ureta et 
al. (26) in  the reverse hexokinase reaction (wherein glucose 
was removed from the reaction mixture) must obviously be 
the allosteric site, which in the absence of glucose binds Glc- 
6-P very  weakly (KD 2 200 pM). Our experiments suggest a 
common locus for Glc-6-P and Pi which can explain their 
antagonism. The stimulation by Pi of the reverse hexokinase 
reaction (31) can also be explained by the competitive binding 
of Glc-6-P  and Pi at  the allosteric site. 
In our model, the potent inhibition by Glc-6-P of the 
forward hexokinase reaction must predominantly be at  the 
allosteric site, which is the only site binding Glc-6-P under 
these conditions. Depending on the relative concentrations of 
glucose and  Glc-6-P, some product inhibition by GIc-6-P can 
also be envisaged. The mechanism of inhibition is likely to be 
the displacement of ATP from the active site by a conforma- 
tional change induced by Glc-6-P  interaction at the allosteric 
site. Because Pi has no effect on the forward hexokinase 
reaction in the absence of Glc-6-P, we assume that  the y- 
phosphate site of ATP is not identical to the phosphate 
subsite to which either  Glc-6-P or Pi binds. A close proximity 
of these  phosphate sites, however,  is not ruled out. 
The apparent cooperativity in glucose binding to brain 
hexokinase, which is a monomeric enzyme (Fig. 3A), is a 
puzzling result and we have  no  obvious way to explain it. The 
only reasonable explanation we can offer is based on our 
previous study (20) that,  at high concentrations, a fraction of 
brain hexokinase exists as a dimer. It is possible that the 
observed cooperativity in the binding of  glucose might arise 
from cooperative interactions between glucose binding sites 
of the dimer. Dimerization is also induced by Glc-6-P, which 
is known to bring about large conformational changes in the 
We have used the term “allosteric site” in a broad sense to include 
the binding of Glc-6-P not only to a site topologically distinct from 
the active site, hut also to any locus within the active site domain, 
but outside ita glucose subsite. 
Glucose-dependent  Allostel 
enzyme (20). However, a  straight-line  Scatchard plot is ob- 
tained for glucose binding in the presence of Glc-6-P. The 
two subunits of the Glc-6-P-induced dimer thus appear to be 
incompetent where cooperative interactions between their 
glucose binding sites is concerned. The dimerization induced 
in brain hexokinase by Glc-6-P is also reversed in the presence 
of Pi (20), which stabilizes the monomeric state. This may 
thus explain the straight line Scatchard plot obtained for 
glucose in the presence of Pi (Fig. 3B) .  
Reduction in the number of binding sites for glucose in  the 
presence of Glc-6-P or Pi is also an intriguing result consid- 
ering the fact that both  these ligands are involved in  inhibition 
and  de-inhibition, respectively, of the enzyme. Although one 
may be tempted to call it half-of-the-sites binding, such a 
conclusion is unwarranted  on the basis of our limited data. A 
proper interpretation of this finding would require an ade- 
quate  and  tested hypothesis to explain the  apparent positive 
cooperativity in glucose binding which is abolished in the 
presence of Pi (Fig. 3 B )  or Glc-6-P. 
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